DMT can be ingested in several ways, but the route of administration dramatically changes how quickly it hits, how intense the experience is, and how long it lasts. The most common methods are vaporizing (inhaling), drinking it in a brew like ayahuasca, and, in clinical research settings, intravenous injection. Each method works differently because of how the body metabolizes DMT.
Why DMT Doesn’t Work If You Just Swallow It
On its own, DMT taken by mouth produces no psychoactive effects. The reason is an enzyme in your gut and liver called monoamine oxidase A (MAO-A), which breaks DMT down into an inactive byproduct before it ever reaches your brain. This breakdown happens so quickly that the compound is essentially neutralized during digestion. This is why every oral method of consuming DMT requires a workaround to block that enzyme.
Oral: Ayahuasca and Pharmahuasca
The traditional solution to DMT’s oral problem is ayahuasca, a brew originating in the Amazon that combines DMT-containing plants with plants rich in compounds called MAO inhibitors (MAOIs), primarily harmine, harmaline, and tetrahydroharmine. These MAOIs temporarily block the enzyme that would otherwise destroy DMT in the gut, allowing it to pass into the bloodstream and cross into the brain.
The interaction between these two components is not one-directional. The MAOIs reduce DMT breakdown, but DMT also alters how the body processes the MAOIs themselves, creating a complex pharmacological relationship that affects both the intensity and variability of the experience from person to person.
After drinking ayahuasca, initial perceptual changes begin around 30 minutes. Effects peak at roughly 1.5 to 2 hours and resolve within 4 to 6 hours. During that window, people report intense perceptual and cognitive changes, shifts in the visual field, heightened emotional sensitivity, and positive mood alterations. Nausea and vomiting are common, particularly in the first hour.
“Pharmahuasca” is a modern, pharmaceutical version of the same concept: pure DMT combined with a purified MAOI in capsule form rather than a plant-based brew. The principle is identical. The MAOI is taken first or simultaneously to protect the DMT from enzymatic breakdown. The timeline and effects closely mirror traditional ayahuasca.
Vaporized (Inhaled)
Vaporizing freebase DMT and inhaling the vapor is the fastest-acting and shortest-lasting method. Typical doses range from 40 to 50 mg, though some users report going as high as 100 mg. The vapor bypasses the digestive system entirely, so no MAOI is needed. DMT enters the bloodstream through the lungs and reaches the brain within seconds.
The onset is almost immediate. Effects peak within the first few minutes, and the entire experience typically lasts 10 to 20 minutes, sometimes with lingering aftereffects for another 20 to 30 minutes. This extremely compressed timeline produces what many describe as the most intense psychedelic experience available, though its brevity also means the acute effects end quickly. In research settings, vaporization of approximately 40 mg has been used to study brain activity changes associated with intense psychedelic states.
Intranasal (Snorted)
DMT can also be insufflated, or snorted. This route is less common than vaporizing or oral consumption but has been studied in clinical settings. When delivered intranasally, effects begin within 0 to 2 minutes, with intensity increasing rapidly between 2 and 8 minutes and peaking around 8 to 15 minutes. The full experience lasts roughly 45 to 60 minutes, with some residual effects lingering up to 90 minutes.
The tradeoff is physical discomfort. Participants in clinical studies consistently report a burning or stinging sensation in the nose during the first few minutes, sometimes extending to a feeling of heat in the head. This physical discomfort tends to fade as the psychoactive effects take hold, but the first five minutes represent a window of peak physical unpleasantness combined with rising anxiety. One participant described it as comparable to a salt spray, while others likened it to the congestion of a cold.
Intravenous (Clinical Research Only)
In controlled research, DMT has been administered by intravenous injection. This is the most precisely dosed method and produces the most predictable blood levels. After IV administration, DMT is eliminated extremely rapidly, with a half-life ranging from about 5 to 19 minutes depending on the study and dosing method. Blood concentrations show a steep initial drop within 10 to 20 minutes as the compound redistributes into other tissues, followed by a slower elimination phase lasting up to about two hours before levels become undetectable.
The subjective effects of IV DMT mirror the compressed timeline of vaporization: near-instant onset, intense peak, and rapid resolution. Researchers have explored continuous IV infusion as a way to extend and stabilize DMT’s effects over longer periods, which is not possible with a single inhaled dose.
Why the Route Matters for Safety
The oral route carries a unique risk because it requires MAO inhibitors to work. MAOIs interact dangerously with a wide range of common substances, including certain antidepressants (particularly SSRIs and SNRIs), stimulants, and some foods high in tyramine. Combining MAOIs with serotonin-boosting drugs can trigger serotonin syndrome, a potentially life-threatening condition involving dangerously high body temperature, rapid heart rate, and seizures. Recreational users experimenting with combining MAOIs and tryptamine compounds have caused fatal outcomes.
Vaporized and intranasal DMT, because they do not require an MAOI, avoid this particular category of drug interaction. However, the intensity and speed of onset with these methods presents its own risks: the rapid shift in consciousness can cause falls, panic, or disorientation, particularly in uncontrolled settings. The near-instantaneous onset of vaporized DMT leaves essentially no adjustment period between sobriety and a full psychedelic state.